Table 3

Modulation of hydroquinone-induced hepatocyte cytotoxicity

Addition% Cytotoxicity at time (min)
3060120180
None23  ± 222  ± 224  ± 326  ± 2
HQ (200 μM)22  ± 225  ± 329  ± 333  ± 2
 " + GSH depleted hepatocytes45  ± 346  ± 248  ± 462  ± 5
 " + dicumarol (25 μM)39  ± 443  ± 453  ± 569  ± 7
HQ (2 mM)32  ± 241  ± 460  ± 43-a 80  ± 5
 " +catalase (100 units/ml)20  ± 223  ± 240  ± 53-b 77  ± 3
 " + SOD (100 units/ml)1001001003-b 100
 " + isoniazid (10 mM)25  ± 234  ± 236  ± 33-b 38  ± 2
 " +ethylenediamine (2 mM)27  ± 349  ± 457  ± 385  ± 3
 " + dicumarol (25 μM)48  ± 365  ± 21003-b 100
 " + deferoxamine (1 mM)25  ± 228  ± 240  ± 33-b 60  ± 4
 " +pyrogallol (100 μM)25  ± 332  ± 244  ± 251  ± 2
 " + sorbitol (10 mM)28  ± 333  ± 436  ± 447  ± 3

Chemicals were incubated with hepatocytes under similar condition to that of Table 2 except that hepatocytes (106 cells/ml) were incubated in Krebs-Henseleit buffer, pH 7.4, at 37 °C under 1% O2/94% N2/5% CO2. Values are expressed as the means of three separate experiments ± S.D. Modulators were not cytotoxic by themselves (data not shown).

  • 3-a  Significant differences from control (p < 0.05).

  • 3-b  Significant differences from the test compound alone (p < 0.05).